The purpose of this randomized , controlled , crossover clinical trial was to evaluate and compare the behavioral differences resulting from the sedative effects of atomized buccal ( transmucosal ) and atomized intranasal ( parenteral ) midazolam ( 0.3 mg/kg ) as a method for sedation of pediatric dental patients .